Swedish Orphan International
HOME ABOUT US THERAPY AREAS & PRODUCTS PATIENTS PARTNERS MEDIA & INVESTOR CAREER CONTACT
Goals, mission and background Business Strategy CEO'S STATEMENT History 10 year overview Press releases News Financial Reports Calendar Image gallery Presentations Corporate Governance
LANGUAGE:
Home / Media & Investor

MEDIA & INVESTOR


Swedish Orphan in one minute

The story about Swedish Orphan International

Want to learn some more?

See what others write about orphan drugs

SWEDISH ORPHAN NEWS

2/19/2010
Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement

Cambridge, Mass and Stockholm, Sweden – ...

1/14/2010
Biovitrum AB (publ) completes the acquisition of Swedish Orphan International Holding AB and resolves on an issue in kind

Biovitrum AB (publ) (”Biovitrum”) has to...

12/7/2009
Press release from the extraordinary shareholders' meeting of Biovitrum (publ)

The information in this press release is...

Archive »

REPORTS

9/7/2009
  • Interim Report Q1 2009/2010
Archive »

PRESENTATIONS

  • Presentation of Swedish Orphan International
Archive »

IR & MEDIA CONTACT

Telephone +46 8 412 98 00
ir.media@swedishorphan.com


 

Swedish Orphan International  Drottninggatan 98   SE-111 60 Stockholm   Telephone +46 8 412 98 00   Fax +46 8 412 98 99   info@swedishorphan.com   Terms of use